IQVIA Holdings | IQV - Selling And Administration Expenses


IQVIA Holdings reported $502M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Accenture USD 2.96B 6.78M Mar/2026
Agilent USD 465M 11M Mar/2026
Bruker USD 242.1M 5.1M Mar/2026
Cardinal Health USD 1.51B 6M Mar/2026
Celltrion KRW 9.32B 3.39B Mar/2026
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cigna USD 3.32B 291M Mar/2026
Cognizant Technology Solutions USD 791M 15M Mar/2026
Computer Programs Systems USD 51.62M 109.74M Dec/2025
Cspc Pharmaceutical CNY 1.87B 95.62M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Deva Holding AS TRY 462.26M 48.18M Sep/2023
Dianthus Therapeutics USD 12.47M 5.89M Mar/2026
Divis Laboratories Ltd INR 3.4B 10M Jun/2025
Elevance Health USD 10.91B 309M Dec/2025
Humana USD 3.36B 614M Mar/2025
IBM USD 4.4B 1.42B Mar/2026
Illumina USD 272M 11M Mar/2026
Infosys INR 10.82B 10.32B Dec/2025
Kangmei Pharma CNY 237.06M 37.35M Mar/2026
Knight Therapeutics CAD 35.45M 4.43M Dec/2025
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Laboratory Of America USD 551M 12.4M Mar/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 1.8B 234M Mar/2026
Mettler Toledo International USD 258.33M 1.5M Mar/2026
Organigram Holdings CAD 22.01M 14.28M Mar/2026
Ovoca Bio EUR 632K 2.33M Jun/2025
Pharma Mar EUR 15.31M 2M Mar/2026
Qiagen NV USD 153.88M 10.77M Dec/2025
Quest Diagnostics USD 504M 0 Mar/2026
Revvity USD 253.88M 2.15M Mar/2026
Sartorius EUR 221.3M 500K Mar/2026
Sino Biopharmaceutical CNY 7.54B 2.23B Jun/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Tilray USD 24.85M 1.7M Sep/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veeva Systems USD 126.47M 1.39M Mar/2026
Veradigm USD 27.28M 5.24M Dec/2022
Waters USD 394M 153.99M Mar/2026
Zealand Pharma A/S 91.81M 99.04M Dec/2025
Zz Pientze Pharmaceu CNY 214.31M 42.4M Mar/2026